KRAS and gallbladder neoplasm: We tested a series of five shRNA constructs in three gallbladder tumor cell lines expressing ERBB2 with wild type KRAS in OCUG1 cells, along with G415 and NOZ cells harboring the KRAS (G13D) and KRAS (G12V) mutant alleles, respectively.